Amglidia

Amglidia is an oral medication containing Glibenclamide, used to manage blood sugar levels in diabetes. This Ammtek-manufactured drug helps regulate insulin production for better glucose control.

Amglidia is primarily used to treat type 2 diabetes by stimulating the pancreas to produce more insulin. It is often prescribed for individuals who cannot control their blood sugar levels through diet and exercise alone. The medication helps lower blood glucose levels, aiding in the management of diabetes symptoms.

Common effects of Amglidia may include mild hypoglycemia, nausea, or dizziness. Some users report increased appetite or weight gain. These effects vary and are not experienced by everyone. Always consult a healthcare provider for personalized advice.

Amglidia should be handled with care, especially by individuals with kidney or liver issues. It is important to monitor blood sugar levels regularly while using this medication. Avoid alcohol, as it can enhance the drug's effects and increase the risk of hypoglycemia.

Amglidia may interact with other medications, including certain antibiotics, antifungal drugs, and nonsteroidal anti-inflammatory drugs (NSAIDs). Always inform your healthcare provider about all medications you are taking to avoid potential interactions.